ROG.SW: Roche Holding AG Financials
Roche Holding AG Income Statement
Total revenue
Net income
Gross margin TTM
73.53%
Operating margin TTM
31.32%
Net profit margin TTM
20.94%
Return on investment TTM
38.1%
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 61,516,000,000 | 62,395,000,000 | 60,441,000,000 | 65,814,000,000 |
| Operating income | 19,264,000,000 | 13,417,000,000 | 15,395,000,000 | 17,476,000,000 |
| Net income | 12,880,000,000 | 8,277,000,000 | 11,498,000,000 | 12,421,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 61,516,000,000 | 62,395,000,000 | 60,441,000,000 | 65,814,000,000 |
| Cost of revenue | 16,281,000,000 | 16,283,000,000 | 16,357,000,000 | 17,938,000,000 |
| Gross profit | 45,235,000,000 | 46,112,000,000 | 44,084,000,000 | 47,876,000,000 |
| Research and development expenses | 13,352,000,000 | 15,304,000,000 | 14,200,000,000 | 15,225,000,000 |
| General and administrative expenses | 15,161,000,000 | 14,896,000,000 | 14,881,000,000 | 14,201,000,000 |
| Selling and marketing expenses | 0 | 0 | 0 | 9,639,000,000 |
| Selling, general and administrative expenses | 15,161,000,000 | 14,896,000,000 | 14,881,000,000 | 14,201,000,000 |
| Other expenses | -2,542,000,000 | 2,495,000,000 | -392,000,000 | 974,000,000 |
| Operating expenses | 25,971,000,000 | 32,695,000,000 | 28,689,000,000 | 30,400,000,000 |
| Cost and expenses | 42,252,000,000 | 48,978,000,000 | 45,046,000,000 | 48,338,000,000 |
| Net interest income | -1,349,000,000 | -988,000,000 | -633,000,000 | -608,000,000 |
| Interest income | 0 | 260,000,000 | 195,000,000 | 0 |
| Interest expense | 1,349,000,000 | 1,248,000,000 | 828,000,000 | 608,000,000 |
| Depreciation and amortization | 3,393,000,000 | 3,423,000,000 | 3,464,000,000 | 3,824,000,000 |
| EBITDA | 22,657,000,000 | 16,619,000,000 | 18,413,000,000 | 20,800,000,000 |
| EBIT | 19,264,000,000 | 13,196,000,000 | 14,939,000,000 | 16,976,000,000 |
| Non-operating income (excl. interest) | 157,000,000 | 221,000,000 | 456,000,000 | 500,000,000 |
| Operating income | 19,264,000,000 | 13,417,000,000 | 15,395,000,000 | 17,476,000,000 |
| Total other income/expenses (net) | -2,291,000,000 | -1,624,000,000 | -1,316,000,000 | -1,149,000,000 |
| Income before tax | 16,973,000,000 | 11,793,000,000 | 14,079,000,000 | 16,368,000,000 |
| Income tax expense | 3,174,000,000 | 2,606,000,000 | 1,721,000,000 | 2,796,000,000 |
| Net income from continuing operations | 13,799,000,000 | 9,187,000,000 | 12,390,000,000 | 13,531,000,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | -32,000,000 | 0 |
| Net income | 12,880,000,000 | 8,277,000,000 | 11,498,000,000 | 12,421,000,000 |
| Net income deductions | 0 | 0 | 0 | 1,000,000 |
| Bottom line net income | 12,880,000,000 | 8,277,000,000 | 11,498,000,000 | 12,420,000,000 |
| EPS | 16 | 10 | 14 | 16 |
| Diluted EPS | 16 | 10 | 14 | 15 |
| Weighted average shares outstanding | 796,000,000 | 797,000,000 | 799,000,000 | 800,000,000 |
| Weighted average diluted shares outstanding | 803,000,000 | 802,000,000 | 804,000,000 | 800,000,000 |
Roche Holding AG Balance Sheet
Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
27,430,000,000%
Total debt / assets MRQ
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total assets | 100,703,000,000 | 101,801,000,000 | 90,468,000,000 | 88,151,000,000 |
| Total liabilities | 62,823,000,000 | 65,640,000,000 | 57,205,000,000 | 56,136,000,000 |
| Total equity | 33,802,000,000 | 31,767,000,000 | 29,315,000,000 | 27,992,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Cash and cash equivalents | 5,582,000,000 | 6,975,000,000 | 5,376,000,000 | 4,991,000,000 |
| Short-term investments | 9,894,000,000 | 10,342,000,000 | 5,134,000,000 | 4,776,000,000 |
| Cash and short-term investments | 15,476,000,000 | 17,317,000,000 | 10,510,000,000 | 9,767,000,000 |
| Net receivables | 11,899,000,000 | 13,485,000,000 | 12,980,000,000 | 13,866,000,000 |
| Accounts receivable | 11,506,000,000 | 11,297,000,000 | 11,021,000,000 | 11,606,000,000 |
| Other receivables | 393,000,000 | 2,188,000,000 | 1,959,000,000 | 2,260,000,000 |
| Inventory | 7,479,000,000 | 7,606,000,000 | 7,749,000,000 | 8,605,000,000 |
| Prepaid expenses | 0 | 1,225,000,000 | 1,144,000,000 | 1,202,000,000 |
| Other current assets | 3,875,000,000 | 403,000,000 | 1,063,000,000 | 376,000,000 |
| Total current assets | 38,729,000,000 | 40,036,000,000 | 33,446,000,000 | 33,816,000,000 |
| Property, plant and equipment (net) | 22,934,000,000 | 23,740,000,000 | 22,939,000,000 | 24,208,000,000 |
| Goodwill | 7,492,000,000 | 7,876,000,000 | 9,390,000,000 | 10,820,000,000 |
| Intangible assets | 19,321,000,000 | 17,303,000,000 | 14,828,000,000 | 20,505,000,000 |
| Goodwill and intangible assets | 26,813,000,000 | 25,179,000,000 | 24,218,000,000 | 31,325,000,000 |
| Long-term investments | 1,125,000,000 | 992,000,000 | 903,000,000 | 1,097,000,000 |
| Tax assets | 8,411,000,000 | 8,569,000,000 | 6,882,000,000 | 6,427,000,000 |
| Other non-current assets | 2,691,000,000 | 3,285,000,000 | 2,080,000,000 | -8,722,000,000 |
| Total non-current assets | 61,974,000,000 | 61,765,000,000 | 57,022,000,000 | 54,335,000,000 |
| Other assets | 0 | 0 | 0 | 0 |
| Total assets | 100,703,000,000 | 101,801,000,000 | 90,468,000,000 | 88,151,000,000 |
| Total payables | 8,646,000,000 | 8,179,000,000 | 5,781,000,000 | 7,048,000,000 |
| Accounts payable | 5,779,000,000 | 3,984,000,000 | 3,524,000,000 | 3,861,000,000 |
| Other payables | 2,867,000,000 | 4,195,000,000 | 2,257,000,000 | 3,187,000,000 |
| Accrued expenses | 0 | 12,800,000,000 | 2,995,000,000 | 3,117,000,000 |
| Short-term debt | 4,206,000,000 | 3,932,000,000 | 4,399,000,000 | 3,960,000,000 |
| Capital lease obligations (current) | 311,000,000 | 325,000,000 | 291,000,000 | 302,000,000 |
| Tax payables | 0 | 3,462,000,000 | 2,257,000,000 | 3,187,000,000 |
| Deferred revenue | 0 | 809,000,000 | 614,000,000 | 601,000,000 |
| Other current liabilities | 14,838,000,000 | 978,000,000 | 10,744,000,000 | 12,211,000,000 |
| Total current liabilities | 28,001,000,000 | 27,023,000,000 | 24,824,000,000 | 27,239,000,000 |
| Long-term debt | 27,430,000,000 | 30,722,000,000 | 24,809,000,000 | 21,391,000,000 |
| Capital lease obligations (non-current) | 1,244,000,000 | 1,375,000,000 | 1,282,000,000 | 891,000,000 |
| Deferred revenue (non-current) | 116,000,000 | 160,000,000 | 227,000,000 | 254,000,000 |
| Deferred tax liabilities (non-current) | 884,000,000 | 832,000,000 | 593,000,000 | 645,000,000 |
| Other non-current liabilities | 5,148,000,000 | 5,528,000,000 | 5,470,000,000 | 5,716,000,000 |
| Total non-current liabilities | 34,822,000,000 | 38,617,000,000 | 32,381,000,000 | 28,897,000,000 |
| Other liabilities | 0 | 0 | 0 | 0 |
| Capital lease obligations | 1,555,000,000 | 1,700,000,000 | 1,573,000,000 | 1,193,000,000 |
| Total liabilities | 62,823,000,000 | 65,640,000,000 | 57,205,000,000 | 56,136,000,000 |
| Treasury stock | 0 | 0 | 0 | 0 |
| Preferred stock | 0 | 0 | 0 | 0 |
| Common stock | 107,000,000 | 107,000,000 | 107,000,000 | 107,000,000 |
| Retained earnings | 48,837,000,000 | 43,842,000,000 | 42,347,000,000 | 38,937,000,000 |
| Additional paid-in capital | 0 | 0 | 0 | 0 |
| Accumulated other comprehensive income/loss | -15,142,000,000 | -12,182,000,000 | -13,139,000,000 | -11,052,000,000 |
| Other stockholders' equity | 0 | 0 | 0 | 0 |
| Total stockholders' equity | 33,802,000,000 | 31,767,000,000 | 29,315,000,000 | 27,992,000,000 |
| Total equity | 37,880,000,000 | 36,161,000,000 | 33,263,000,000 | 32,015,000,000 |
| Minority interest | 4,078,000,000 | 4,394,000,000 | 3,948,000,000 | 4,023,000,000 |
| Total liabilities and total equity | 100,703,000,000 | 101,801,000,000 | 90,468,000,000 | 88,151,000,000 |
| Total investments | 11,019,000,000 | 11,334,000,000 | 6,037,000,000 | 5,873,000,000 |
| Total debt | 33,191,000,000 | 36,354,000,000 | 30,782,000,000 | 26,544,000,000 |
| Net debt | 27,609,000,000 | 29,379,000,000 | 25,406,000,000 | 21,553,000,000 |
Roche Holding AG Cash Flow Statement
Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Cash from operations | 17,830,000,000 | 20,094,000,000 | 16,095,000,000 | 17,890,000,000 |
| Cash from investing | -8,710,000,000 | -11,393,000,000 | -10,643,000,000 | -3,568,000,000 |
| Cash from financing | -10,179,000,000 | -6,819,000,000 | -4,239,000,000 | -15,718,000,000 |
| Net change in cash | -1,393,000,000 | 1,599,000,000 | 385,000,000 | -1,859,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Net income | 12,880,000,000 | 9,187,000,000 | 11,498,000,000 | 12,421,000,000 |
| Depreciation and amortization | 3,386,000,000 | 3,430,000,000 | 3,474,000,000 | 3,824,000,000 |
| Deferred income tax | 0 | 0 | 0 | -1,658,000,000 |
| Stock-based compensation | 857,000,000 | 855,000,000 | 830,000,000 | 738,000,000 |
| Change in working capital | -1,657,000,000 | 1,161,000,000 | -1,107,000,000 | -2,418,000,000 |
| Accounts receivable | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 |
| Accounts payable | 0 | 0 | 0 | 0 |
| Other working capital | -1,657,000,000 | 1,161,000,000 | -1,107,000,000 | -2,418,000,000 |
| Other non-cash items | 6,607,000,000 | 5,461,000,000 | 1,400,000,000 | 4,983,000,000 |
| Net cash from operating activities | 17,830,000,000 | 20,094,000,000 | 16,095,000,000 | 17,890,000,000 |
| Investments in property, plant and equipment | -5,779,000,000 | -3,529,000,000 | -3,742,000,000 | -4,552,000,000 |
| Acquisitions (net) | -2,923,000,000 | -2,835,000,000 | -5,488,000,000 | -162,000,000 |
| Purchases of investments | -263,000,000 | -5,196,000,000 | -832,000,000 | -271,000,000 |
| Sales/maturities of investments | 295,000,000 | 198,000,000 | 125,000,000 | 1,398,000,000 |
| Other investing activities | -40,000,000 | -31,000,000 | -706,000,000 | 19,000,000 |
| Net cash from investing activities | -8,710,000,000 | -11,393,000,000 | -10,643,000,000 | -3,568,000,000 |
| Net debt issuance | -155,000,000 | 3,819,000,000 | 5,785,000,000 | -5,698,000,000 |
| Long-term net debt issuance | -811,000,000 | 4,528,000,000 | 6,591,000,000 | -6,991,000,000 |
| Short-term net debt issuance | -155,000,000 | -709,000,000 | -806,000,000 | 1,293,000,000 |
| Net stock issuance | -987,000,000 | -1,130,000,000 | -1,144,000,000 | -1,257,000,000 |
| Net common stock issuance | -987,000,000 | -1,130,000,000 | -1,144,000,000 | -1,257,000,000 |
| Common stock issuance | 0 | -1,130,000,000 | 0 | -1,257,000,000 |
| Common stock repurchased | -987,000,000 | -1,130,000,000 | -1,144,000,000 | -1,257,000,000 |
| Net preferred stock issuance | 0 | 0 | 0 | 0 |
| Net dividends paid | -8,385,000,000 | -7,650,000,000 | -7,590,000,000 | -7,446,000,000 |
| Common dividends paid | -8,385,000,000 | -7,650,000,000 | -7,590,000,000 | -7,446,000,000 |
| Preferred dividends paid | 0 | 0 | 0 | 0 |
| Other financing activities | -652,000,000 | -1,858,000,000 | -1,290,000,000 | -1,317,000,000 |
| Net cash from financing activities | -10,179,000,000 | -6,819,000,000 | -4,239,000,000 | -15,718,000,000 |
| Effect of FX changes on cash | -334,000,000 | -283,000,000 | -828,000,000 | -463,000,000 |
| Net change in cash | -1,393,000,000 | 1,599,000,000 | 385,000,000 | -1,859,000,000 |
| Cash at end of period | 5,582,000,000 | 6,975,000,000 | 5,376,000,000 | 4,991,000,000 |
| Cash at beginning of period | 6,975,000,000 | 5,376,000,000 | 4,991,000,000 | 6,850,000,000 |
| Operating cash flow | 17,830,000,000 | 20,094,000,000 | 16,095,000,000 | 17,890,000,000 |
| Capital expenditure | -3,748,000,000 | -5,009,000,000 | -4,649,000,000 | -4,552,000,000 |
| Free cash flow | 14,082,000,000 | 15,085,000,000 | 11,446,000,000 | 13,338,000,000 |
| Income taxes paid | 0 | 0 | 0 | 0 |
| Interest paid | 0 | 0 | 0 | 0 |